Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Research & Development: 2010-2025

Historic Research & Development for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $61625.0.

  • Cryo Cell International's Research & Development fell 6822.36% to $61625.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $423190.0, marking a year-over-year decrease of 6410.58%. This contributed to the annual value of $1.2 million for FY2024, which is 606.77% up from last year.
  • Cryo Cell International's Research & Development amounted to $61625.0 in Q3 2025, which was down 6822.36% from $131711.0 recorded in Q2 2025.
  • Cryo Cell International's 5-year Research & Development high stood at $502889.0 for Q1 2024, and its period low was $3237.0 during Q2 2021.
  • In the last 5 years, Cryo Cell International's Research & Development had a median value of $98143.0 in 2025 and averaged $165270.0.
  • In the last 5 years, Cryo Cell International's Research & Development surged by 239910.41% in 2022 and then tumbled by 8048.42% in 2025.
  • Quarter analysis of 5 years shows Cryo Cell International's Research & Development stood at $30439.0 in 2021, then soared by 151.0% to $76401.0 in 2022, then skyrocketed by 480.89% to $443808.0 in 2023, then tumbled by 31.36% to $304629.0 in 2024, then crashed by 79.77% to $61625.0 in 2025.
  • Its Research & Development stands at $61625.0 for Q3 2025, versus $131711.0 for Q2 2025 and $98143.0 for Q1 2025.